Could a Two-Drug combo beat standard care for BPH?
NCT ID NCT06944145
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding raloxifene to the standard drug finasteride works better than finasteride alone for men with an enlarged prostate (BPH). About 242 adults will take either the combo or finasteride plus a placebo for 12 months. The goal is to see if the combo improves urinary symptoms more than the single drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- finasteride and raloxifene
- What this could lead to
- If successful, this combination could offer a more effective treatment option for men with BPH who don't respond to finasteride alone.
- What could go wrong
- This is a mid-stage trial with 242 participants, so results may not apply to everyone. Adding raloxifene also carries risks like blood clots, which are already listed as an exclusion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BPH (BENIGN PROSTATIC HYPERPLASIA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
RECRUITINGBoston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Needle-Free prostate treatment match implant surgery?
- Can sound waves offer a lasting fix for prostate problems?
- Robotic precision could transform prostate surgery
- Can a disposable scope make prostate surgery faster and cheaper?
- Diabetes drug class may change how the bladder behaves
- Leg patch may ease bladder troubles after prostate surgery